null

SMILES: COc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)-c2ccccc2NS(C)(=O)=O)cc1

InChI Key: InChIKey=IAXJUOFHCLKDII-XMMPIXPASA-N

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 454206   

Target/Host (Institution)	Ligand	Target/Host Links	Ligand Links	Trg + Lig Links	Ki nM	ΔG° kcal/mole	IC50 nM	Kd nM	EC50/IC50 nM	koff s-1	kon M-1s-1	pH	Temp °C
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454206 (US10717708, Example 199 | US11186544, Example 199) Show SMILES COc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)-c2ccccc2NS(C)(=O)=O)cc1 |r| Show InChI InChI=1S/C26H28N4O5S/c1-35-21-15-11-19(12-16-21)27-26(32)28-24-8-5-17-30(25(24)31)20-13-9-18(10-14-20)22-6-3-4-7-23(22)29-36(2,33)34/h3-4,6-7,9-16,24,29H,5,8,17H2,1-2H3,(H2,27,28,32)/t24-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	0.280	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454206 (US10717708, Example 199 | US11186544, Example 199) Show SMILES COc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)-c2ccccc2NS(C)(=O)=O)cc1 |r| Show InChI InChI=1S/C26H28N4O5S/c1-35-21-15-11-19(12-16-21)27-26(32)28-24-8-5-17-30(25(24)31)20-13-9-18(10-14-20)22-6-3-4-7-23(22)29-36(2,33)34/h3-4,6-7,9-16,24,29H,5,8,17H2,1-2H3,(H2,27,28,32)/t24-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	140	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
N-formyl peptide receptor 2 (Homo sapiens (Human))	BDBM454206 (US10717708, Example 199 | US11186544, Example 199) Show SMILES COc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)-c2ccccc2NS(C)(=O)=O)cc1 |r| Show InChI InChI=1S/C26H28N4O5S/c1-35-21-15-11-19(12-16-21)27-26(32)28-24-8-5-17-30(25(24)31)20-13-9-18(10-14-20)22-6-3-4-7-23(22)29-36(2,33)34/h3-4,6-7,9-16,24,29H,5,8,17H2,1-2H3,(H2,27,28,32)/t24-/m1/s1	PDB NCI pathway Reactome pathway KEGG UniProtKB/SwissProt antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem		n/a	n/a	n/a	n/a	0.280	n/a	n/a	n/a	n/a
TBA									Citation and Details
					More data for this Ligand-Target Pair
fMet-Leu-Phe receptor (Homo sapiens (Human))	BDBM454206 (US10717708, Example 199 | US11186544, Example 199) Show SMILES COc1ccc(NC(=O)N[C@@H]2CCCN(C2=O)c2ccc(cc2)-c2ccccc2NS(C)(=O)=O)cc1 |r| Show InChI InChI=1S/C26H28N4O5S/c1-35-21-15-11-19(12-16-21)27-26(32)28-24-8-5-17-30(25(24)31)20-13-9-18(10-14-20)22-6-3-4-7-23(22)29-36(2,33)34/h3-4,6-7,9-16,24,29H,5,8,17H2,1-2H3,(H2,27,28,32)/t24-/m1/s1	PDB Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet	PC cid PC sid UniChem	US Patent	n/a	n/a	n/a	n/a	140	n/a	n/a	n/a	n/a
Bristol-Myers Squibb Company US Patent					Assay Description FPR2 and FPR1 Cyclic Adenosine Monophosphate (cAMP) Assays. A mixture of forskolin (5 μM final for FPR2 or 10 μM final for FPR1) and IBMX (...				US Patent US10717708 (2020)
					More data for this Ligand-Target Pair